<DOC>
	<DOC>NCT02593279</DOC>
	<brief_summary>The aim of the study is to describe asthma phenotype with small airways dysfunction, in a multiparametric manner, with clinical, biological, morphological and genetic elements compared with asthma with proximal airways obstruction. The objective of this study is also to complete the clinical, immunobiological and morphological analysis of asthma with small airways dysfunction.</brief_summary>
	<brief_title>AVAD: Asthma With Small Airways Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>General man or woman age ≥ 18 years asthma inform consent signed affiliated to health insurance Specific inclusion criteria : asthma with proximal airways obstruction GROUP Maximal Voluntary Ventilation (MMV)&lt;80% MMV / Forced Vital Capacity (FVC)≤70% Carbon Monoxide Transfer Coefficient (KcO)&gt;80% Specific inclusion criteria : asthma with small airways dysfunction GROUP Maximal Voluntary Ventilation (MMV)≥80% MMV / Vital Capacity(VC)&gt;70% Carbon Monoxide Transfer Coefficient (KcO)&gt;80% General pregnant woman or breastfeeding patient participating to other biomedical research patient who have participated to other biomedical research within the past 3 months patient refusing to sign the inform consent Specific exclusion criteria : Patient who stopped smoking since less than 12 months Pathological state related to obstructive distal airway damage Bronchopulmonary infectious disease within the past 4 weeks Solid tumor curated by chemotherapy or chest radiotherapy Chronic respiratory disease Asthma exacerbation within the past 3 months Oral or systemic corticotherapy within the past 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>phenotype</keyword>
	<keyword>small</keyword>
	<keyword>airway</keyword>
	<keyword>proximal</keyword>
	<keyword>dysfunction</keyword>
</DOC>